8-KItem 2.02 · Results of OperationsItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
Cardinal Health reports higher fiscal 2026 earnings and issues FY2027 guidance
Filed with the SEC on · Summarized by InvestorsBot
Cardinal Health reported fourth-quarter fiscal 2026 revenue of $63.7 billion, up 6%, and non-GAAP diluted EPS of $2.91, up 40%, including a $0.31 per-share benefit from a one-time $100 million IEEPA tariff refund; full-year revenue reached $254.2 billion and non-GAAP EPS was $11.26. For fiscal 2027, the company guided to non-GAAP EPS of $12.40 to $12.60, or 13% to 15% growth excluding the tariff refund, and authorized an additional $5.0 billion in share repurchases after buying back $1.4 billion during fiscal 2026.